India Interventional Radiology Products Market

ID: MRFR/MED/50183-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026
India Interventional Radiology Products Market Research Report: Size, Share, Trend Analysis By Product Type (Catheters, Guide Wires, Embolic Agents, Radiology Visualization Systems, Ablation Devices), By Procedure Type (Angiography, Biliary Interventions, Biopsy, Drainage Procedures, Ablation), By End Users (Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers) and By Applications (Oncology, Cardiology, Urology, Neurology) - Growth Outlook & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Interventional Radiology Products Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)5.8%
2024 Market Size$ 1,417.75 Million
2025 Market Size$ 1,499.98 Million
2035 Market Size$ 2,636.55 Million

Key Players

Medtronic
Boston Scientific
Siemens Healthineers
Johnson & Johnson
Bayer
Abbott Laboratories
Trends
  • Technological Advancements
  • Rising Demand for Minimally Invasive Procedures
  • Regulatory Support and Healthcare Initiatives
Opportunities
  • Surge in Medical Tourism
  • Rising Awareness and Education
  • Growth in Healthcare Infrastructure
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Life Sciences, BY Product Type (USD Million)
      1. 4.1.1 Catheters
      2. 4.1.2 Guide Wires
      3. 4.1.3 Embolic Agents
      4. 4.1.4 Radiology Visualization Systems
      5. 4.1.5 Ablation Devices
    2. 4.2 Life Sciences, BY Procedure Type (USD Million)
      1. 4.2.1 Angiography
      2. 4.2.2 Biliary Interventions
      3. 4.2.3 Biopsy
      4. 4.2.4 Drainage Procedures
      5. 4.2.5 Ablation
    3. 4.3 Life Sciences, BY End User (USD Million)
      1. 4.3.1 Hospitals
      2. 4.3.2 Ambulatory Surgical Centers
      3. 4.3.3 Diagnostic Imaging Centers
    4. 4.4 Life Sciences, BY Application (USD Million)
      1. 4.4.1 Oncology
      2. 4.4.2 Cardiology
      3. 4.4.3 Urology
      4. 4.4.4 Neurology
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Life Sciences
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Boston Scientific (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Siemens Healthineers (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Johnson & Johnson (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Bayer (DE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Abbott Laboratories (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Terumo Corporation (JP)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Cook Medical (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Philips Healthcare (NL)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 INDIA MARKET ANALYSIS BY PRODUCT TYPE
    3. 6.3 INDIA MARKET ANALYSIS BY PROCEDURE TYPE
    4. 6.4 INDIA MARKET ANALYSIS BY END USER
    5. 6.5 INDIA MARKET ANALYSIS BY APPLICATION
    6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
    9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
    11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
    12. 6.12 LIFE SCIENCES, BY PRODUCT TYPE, 2024 (% SHARE)
    13. 6.13 LIFE SCIENCES, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 LIFE SCIENCES, BY PROCEDURE TYPE, 2024 (% SHARE)
    15. 6.15 LIFE SCIENCES, BY PROCEDURE TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
    17. 6.17 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
    18. 6.18 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
    19. 6.19 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY PROCEDURE TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY END USER, 2025-2035 (USD Million)
      4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

India Life Sciences Market Segmentation

Life Sciences By Product Type (USD Million, 2025-2035)

  • Catheters
  • Guide Wires
  • Embolic Agents
  • Radiology Visualization Systems
  • Ablation Devices

Life Sciences By Procedure Type (USD Million, 2025-2035)

  • Angiography
  • Biliary Interventions
  • Biopsy
  • Drainage Procedures
  • Ablation

Life Sciences By End User (USD Million, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers

Life Sciences By Application (USD Million, 2025-2035)

  • Oncology
  • Cardiology
  • Urology
  • Neurology

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035